Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 3
2012 17
2013 1
2014 4
2015 3
2016 3
2017 5
2019 5
2020 6
2022 3
2023 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Related Articles by Review for PMID: 31643851

33 results

Results by year

Filters applied: . Clear all
Page 1
Cabazitaxel.
[No authors listed] [No authors listed] 2020 Sep 7. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2020 Sep 7. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643851 Free Books & Documents. Review.
Preclinical profile of cabazitaxel.
Vrignaud P, Semiond D, Benning V, Beys E, Bouchard H, Gupta S. Vrignaud P, et al. Drug Des Devel Ther. 2014 Oct 13;8:1851-67. doi: 10.2147/DDDT.S64940. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 25378905 Free PMC article. Review.
Current development of cabazitaxel drug delivery systems.
Sun B, Lovell JF, Zhang Y. Sun B, et al. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Mar;15(2):e1854. doi: 10.1002/wnan.1854. Epub 2022 Sep 25. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023. PMID: 36161272 Review.
Sequencing impact and prognostic factors in metastatic castration-resistant prostate cancer patients treated with cabazitaxel: A systematic review and meta-analysis.
Yanagisawa T, Kawada T, Rajwa P, Mostafaei H, Motlagh RS, Quhal F, Laukhtina E, König F, Pallauf M, Pradere B, Karakiewicz PI, Nyirady P, Kimura T, Egawa S, Shariat SF. Yanagisawa T, et al. Urol Oncol. 2023 Apr;41(4):177-191. doi: 10.1016/j.urolonc.2022.06.018. Epub 2022 Aug 13. Urol Oncol. 2023. PMID: 35970698 Free article. Review.
33 results